Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis

BACKGROUND: Non-Langerhans cell histiocytosis, including Erdheim–Chester disease (ECD), Rosai–Dorfman disease (RDD), indeterminate cell histiocytosis (ICH), and unclassified histiocytosis, is a rare disorder lacking a standard treatment strategy. We report our experience using intermediate-dose cyta...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ting, Cai, Hua-cong, Cai, Hao, Chen, Miao, Zhang, Wei, Li, Jian, Zhou, Dao-bin, Cao, Xin-xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822720/
https://www.ncbi.nlm.nih.gov/pubmed/35130950
http://dx.doi.org/10.1186/s13023-022-02193-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822720/
https://www.ncbi.nlm.nih.gov/pubmed/35130950
http://dx.doi.org/10.1186/s13023-022-02193-0

Ejemplares similares